Impact of co-payments in public sector on development of antibiotic resistance

Out-of-pocket health expenditures highly related to antimicrobial resistance in low- to middle-income countries(The Lancet Infectious disease)

The decreasing effectiveness of antimicrobial agents is a growing global public health concern. Low income and middle-income countries are vulnerable to the loss of antimicrobial efficacy because of their high burden of infectious disease and the cost of treating resistant organisms. We aimed to assess if copayments in the public sector promoted the development of antibiotic resistance by inducing patients to purchase treatment from less well-regulated private providers.

Link to original article here

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s